BioCentury
ARTICLE | Financial News

Rexahn completes direct public offering

September 19, 2016 7:00 AM UTC

Rexahn Pharmaceuticals Inc. (NYSE-M:RNN), Rockville, Md. Business: Cancer, Neurology, Genitourinary Date completed: 2016-09-14 Type: Direct public offering Raised: $6 million Units: 24 million Price: ...